This is the second publication of Clinical Development Plans from the National Cancer Institute, Division of Cancer Prevention and Control, Chemoprevention Branch and Agent Development Committee. The Clinical Development Plans summarize the status of promising chemopreventive agents regarding evidence for safety and chemopreventive efficacy in preclinical and clinical studies. They also contain the strategy for further development of these drugs, addressing pharmacodynamics, drug effect measurements, intermediate biomarkers for monitoring efficacy, toxicity, supply and formulation, regulatory approval, and proposed clinical trials. Sixteen new Clinical Development Plans are presented here: curcumin, dehydroepiandrosterone, folic acid, genistein, indole-3-carbino1, perillyl alcohol, phenethyl isothiocyanate, 9-cis-retinoic acid, 13-cis-retinoic acid, Z-selenomethionine and 1,4-phenylenebis(methylene)selenocyanate, sulindac sulfone, tea, ursodiol, vitamin A, and (+)-vorozole. The objective of publishing these plans is to stimulate interest and thinking among the scientific community on the prospects for developing these and future generations of chemopreventive drugs. 0 1997 Wiley-Liss, Inc.
Lasting changes in the properties of cultured diploid human cells may be produced by a number of factors. Oncogenic viruses "transform" cells, with associated karyotypic changes and the appearance of a variety of new phenotypic characters; and rare spontaneous transformations may produce a similar spectrum of changes.", 2 The gradual "senescence" of serially passaged diploid human cells is evidenced in a progressively slower growth rate, late cytologic and karyotypic changes, and ultimate death.3 Often unrecognized contamination with mycoplasma may also cause changes in metabolic activity. In addition, compaction of growing cells in a monolayer is usually accompanied by a reversible inhibition of motion, macromolecular synthesis, and growth.2 4 Possibly related to the latter effects, certain enzymatic activities5 and specialized biochemical functions6 are markedly influenced by population density.The present communication describes far-reaching and stable changes in the pattern of RNA synthesis which occurred regularly in human diploid cell strains serially propogated in this laboratory, and which were apparently unrelated to any of the foregoing factors.Methods.-Cultures: The cell strains used were all human diploid fibroblasts, five deriving from fetal tissues (adrenal, bone, conjunctiva, skin, and thymus) and three from juvenile skin, one normal (F 1), one galactosemic (Detroit 510), and one hyperglycinemic (BAL). Their source and methods for propagation have been described elsewhere.' Periodic tests of these strains for mycoplasma contaminations in particular after the change in the pattern of RNA synthesis as here described, were generally negative. Cultures were maintained in the presence of penicillin, streptomycin, and aureomycin (5,5, and 10 y/ml, respectively); and tests for mycoplasma were carried out after at least two subcultures in aureomycin-free medium. In nine attempted cultivations of eight different altered cell lines, positive isolations were reported in one. (Three positive results in a single shipment of bacteriologically contaminated specimens are not here included.) Electron microscope examination by Dr. Elliott Robbins of this institution showed no evidence of mycoplasma.Karyotypic examinations of these lines, generously carried out by Dr. Harold P. Klinger, showed them to be euploid after the altered pattern of RNA synthesis to be described had been established.Analysis of cellular RNA: (1) Pulse-labeling and preparation of extracts: Monolayer cultures were pulse-labeled with C'4-uridine (Schwarz BioResearch, Inc., 24-39 jc/millimole, used at 0.05-0.20 ,uc/ml; carrier uridine at 0.008 mM was sometimes added). Incorporation was stopped at appropriate times by decanting the pulsing medium, and washing the cell sheet twice with cold Hanks' salt solution. Nuclear and cytoplasmic fractions were prepared by Dounce homogenization of cells harvested with crystalline trypsin and trypsin inhibitor at 0°as previously described.4, 8 Cytoplasmic fractions were analyzed by sucrose density centrifuga...
CAS Name (9CI): (Z)-5-Fluoro-2-methyl-l-(~4-(methylsulfinyl)phenyl)methylene)- 1H-indene-3-acetic AcidSynonyms: Clinoril@' (Active Ingredient) Related Compounds:Sulindac Sulfone (Z)-5-Fluoro-2-methy1-1-((4-methylsulfonyl)phenylmethylene)-1 H-indene-3-acetic Acid FGN-1 Sulindac Sulfide (Z)-5-Fluoro-2-methy1-1-(pmethylthiobenzylidene)-3indenylacetic AcidStructure: 0 EXECUTIVE SUMMARY was discovered in a search for a less toxic version of indomethacin, a structurally related compound. Sulindac is indicated for acute and long-term treatment of the symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, shoulder bursitis/ tendinitis, and acute gouty arthritis at doses of 200 to 400 mg qd (ca. 0.008-0.016 mmol/kg-bw qd) [2].In case studies, sulindac seemed effective in pre-Sulindac is an FDA-approved non-steroidal antiinflammatory (NSAID), antipyretic, and analgesic. As with the other NSAIDs currently being considered by the CB for further development (aspirin, ibuprofen, and piroxicam), sulindac derives its activity from inhibition of cyclooxygenase 11,21. It
CAS Name (9CI): 4-Methyl-5-pyrazinyl-3H-1,2-dithiol-3-thione Synonyms: RP 35972Structure:
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.